Michael Tagen

4PUBLICATIONS
6CO-AUTHORS
Biologically active moleculesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 03, 2025
CB1 Receptor Antagonist Selonabant (ANEB-001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled Trial.

Andriy A Gorbenko, Jules A A C Heuberger, Maria Juachon

|Nov 22, 2023
Pharmacokinetics of Two Nanoemulsion Formulations of Δ8-Tetrahydrocannabinol in Rats.

Michael Tagen, Linda E Klumpers, Alexey Peshkovsky

|Aug 12, 2023
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.

Michael Tagen, Daniel Mantuani, Liron van Heerden

|May 06, 2022
Review of delta-8-tetrahydrocannabinol (Δ8 -THC): Comparative pharmacology with Δ9 -THC.

Michael Tagen, Linda E Klumpers

Pageof 1

Frequent Collaborators

3 joint publications

Linda E Klumpers

1 joint publications

Andriy A Gorbenko

1 joint publications

Jules A A C Heuberger

1 joint publications

Maria Juachon